▶ 調査レポート

解熱鎮痛剤の世界市場(~2026年)

• 英文タイトル:Global Antipyretic Analgesics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。解熱鎮痛剤の世界市場(~2026年) / Global Antipyretic Analgesics Market Size, Status and Forecast 2020-2026 / MRC2-11QY10877資料のイメージです。• レポートコード:MRC2-11QY10877
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は解熱鎮痛剤のグローバル市場について調査・分析したレポートです。種類別(パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他)市場規模、用途別(成人、子供)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別解熱鎮痛剤の競争状況、市場シェア
・世界の解熱鎮痛剤市場:種類別市場規模 2015年-2020年(パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他)
・世界の解熱鎮痛剤市場:種類別市場規模予測 2021年-2026年(パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他)
・世界の解熱鎮痛剤市場:用途別市場規模 2015年-2020年(成人、子供)
・世界の解熱鎮痛剤市場:用途別市場規模予測 2021年-2026年(成人、子供)
・北米の解熱鎮痛剤市場分析:米国、カナダ
・ヨーロッパの解熱鎮痛剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの解熱鎮痛剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の解熱鎮痛剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの解熱鎮痛剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Mallinckrodt Pharmaceuticals、IOL、Anqiu Lu'an Pharmaceutical、Novacyl、BASF、Anhui BBCA Pharmaceuticals、Hubei Biocause、Xinhua Pharm、Granules India Limited、Huagang Pharm、Hebei Jiheng Pharmaceutical、Zhejiang Kangle Pharmaceutical
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Antipyretic Analgesics is a kind of medicine with the function antipyretic and analgesia, most of which has the function of anti-inflammatory and antirheumatic. The report collects data of Antipyretic Analgesics bulk drug market, and analyzes the status and forecast of global Antipyretic Analgesics market, from the perspective of key players, regions, types and applications, etc.
Antipyretic Analgesics could be sub-segmented into adults and children, by application. In 2019, adults is the major section of global Antipyretic Analgesics market, with a market share of over 76%, while children accounted for about 24%.
Currently key players of global Antipyretic Analgesics market include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu’an Pharmaceutical, etc. The top 3 manufacturers took up approximately 25% of global market.

Market Analysis and Insights: Global Antipyretic Analgesics Market
The global Antipyretic Analgesics market size is projected to reach US$ 2952.5 million by 2026, from US$ 2745.3 million in 2020, at a CAGR of 1.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antipyretic Analgesics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antipyretic Analgesics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antipyretic Analgesics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antipyretic Analgesics market.

Global Antipyretic Analgesics Scope and Market Size
Antipyretic Analgesics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antipyretic Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Market segment by Application, split into
Adults
Children

Based on regional and country-level analysis, the Antipyretic Analgesics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

In the competitive analysis section of the report, leading as well as prominent players of the global Antipyretic Analgesics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipyretic Analgesics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antipyretic Analgesics Market Share by Application: 2020 VS 2026
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antipyretic Analgesics Market Perspective (2015-2026)
2.2 Global Antipyretic Analgesics Growth Trends by Regions
2.2.1 Antipyretic Analgesics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antipyretic Analgesics Historic Market Share by Regions (2015-2020)
2.2.3 Antipyretic Analgesics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antipyretic Analgesics Players by Market Size
3.1.1 Global Top Antipyretic Analgesics Players by Revenue (2015-2020)
3.1.2 Global Antipyretic Analgesics Revenue Market Share by Players (2015-2020)
3.2 Global Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antipyretic Analgesics Revenue
3.4 Global Antipyretic Analgesics Market Concentration Ratio
3.4.1 Global Antipyretic Analgesics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipyretic Analgesics Revenue in 2019
3.5 Key Players Antipyretic Analgesics Area Served
3.6 Key Players Antipyretic Analgesics Product Solution and Service
3.7 Date of Enter into Antipyretic Analgesics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antipyretic Analgesics Breakdown Data by Type (2015-2026)
4.1 Global Antipyretic Analgesics Historic Market Size by Type (2015-2020)
4.2 Global Antipyretic Analgesics Forecasted Market Size by Type (2021-2026)

5 Antipyretic Analgesics Breakdown Data by Application (2015-2026)
5.1 Global Antipyretic Analgesics Historic Market Size by Application (2015-2020)
5.2 Global Antipyretic Analgesics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Antipyretic Analgesics Market Size (2015-2026)
6.2 North America Antipyretic Analgesics Market Size by Type (2015-2020)
6.3 North America Antipyretic Analgesics Market Size by Application (2015-2020)
6.4 North America Antipyretic Analgesics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Antipyretic Analgesics Market Size (2015-2026)
7.2 Europe Antipyretic Analgesics Market Size by Type (2015-2020)
7.3 Europe Antipyretic Analgesics Market Size by Application (2015-2020)
7.4 Europe Antipyretic Analgesics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antipyretic Analgesics Market Size (2015-2026)
8.2 Asia-Pacific Antipyretic Analgesics Market Size by Type (2015-2020)
8.3 Asia-Pacific Antipyretic Analgesics Market Size by Application (2015-2020)
8.4 Asia-Pacific Antipyretic Analgesics Market Size by Country (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia

9 Latin America
9.1 Latin America Antipyretic Analgesics Market Size (2015-2026)
9.2 Latin America Antipyretic Analgesics Market Size by Type (2015-2020)
9.3 Latin America Antipyretic Analgesics Market Size by Application (2015-2020)
9.4 Latin America Antipyretic Analgesics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antipyretic Analgesics Market Size (2015-2026)
10.2 Middle East & Africa Antipyretic Analgesics Market Size by Type (2015-2020)
10.3 Middle East & Africa Antipyretic Analgesics Market Size by Application (2015-2020)
10.4 Middle East & Africa Antipyretic Analgesics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Company Details
11.1.2 Mallinckrodt Pharmaceuticals Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Introduction
11.1.4 Mallinckrodt Pharmaceuticals Revenue in Antipyretic Analgesics Business (2015-2020))
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
11.2 IOL
11.2.1 IOL Company Details
11.2.2 IOL Business Overview
11.2.3 IOL Antipyretic Analgesics Introduction
11.2.4 IOL Revenue in Antipyretic Analgesics Business (2015-2020)
11.2.5 IOL Recent Development
11.3 Anqiu Lu’an Pharmaceutical
11.3.1 Anqiu Lu’an Pharmaceutical Company Details
11.3.2 Anqiu Lu’an Pharmaceutical Business Overview
11.3.3 Anqiu Lu’an Pharmaceutical Antipyretic Analgesics Introduction
11.3.4 Anqiu Lu’an Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020)
11.3.5 Anqiu Lu’an Pharmaceutical Recent Development
11.4 Novacyl
11.4.1 Novacyl Company Details
11.4.2 Novacyl Business Overview
11.4.3 Novacyl Antipyretic Analgesics Introduction
11.4.4 Novacyl Revenue in Antipyretic Analgesics Business (2015-2020)
11.4.5 Novacyl Recent Development
11.5 BASF
11.5.1 BASF Company Details
11.5.2 BASF Business Overview
11.5.3 BASF Antipyretic Analgesics Introduction
11.5.4 BASF Revenue in Antipyretic Analgesics Business (2015-2020)
11.5.5 BASF Recent Development
11.6 Anhui BBCA Pharmaceuticals
11.6.1 Anhui BBCA Pharmaceuticals Company Details
11.6.2 Anhui BBCA Pharmaceuticals Business Overview
11.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Introduction
11.6.4 Anhui BBCA Pharmaceuticals Revenue in Antipyretic Analgesics Business (2015-2020)
11.6.5 Anhui BBCA Pharmaceuticals Recent Development
11.7 Hubei Biocause
11.7.1 Hubei Biocause Company Details
11.7.2 Hubei Biocause Business Overview
11.7.3 Hubei Biocause Antipyretic Analgesics Introduction
11.7.4 Hubei Biocause Revenue in Antipyretic Analgesics Business (2015-2020)
11.7.5 Hubei Biocause Recent Development
11.8 Xinhua Pharm
11.8.1 Xinhua Pharm Company Details
11.8.2 Xinhua Pharm Business Overview
11.8.3 Xinhua Pharm Antipyretic Analgesics Introduction
11.8.4 Xinhua Pharm Revenue in Antipyretic Analgesics Business (2015-2020)
11.8.5 Xinhua Pharm Recent Development
11.9 Granules India Limited
11.9.1 Granules India Limited Company Details
11.9.2 Granules India Limited Business Overview
11.9.3 Granules India Limited Antipyretic Analgesics Introduction
11.9.4 Granules India Limited Revenue in Antipyretic Analgesics Business (2015-2020)
11.9.5 Granules India Limited Recent Development
11.10 Huagang Pharm
11.10.1 Huagang Pharm Company Details
11.10.2 Huagang Pharm Business Overview
11.10.3 Huagang Pharm Antipyretic Analgesics Introduction
11.10.4 Huagang Pharm Revenue in Antipyretic Analgesics Business (2015-2020)
11.10.5 Huagang Pharm Recent Development
11.11 Hebei Jiheng Pharmaceutical
10.11.1 Hebei Jiheng Pharmaceutical Company Details
10.11.2 Hebei Jiheng Pharmaceutical Business Overview
10.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Introduction
10.11.4 Hebei Jiheng Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020)
10.11.5 Hebei Jiheng Pharmaceutical Recent Development
11.12 Zhejiang Kangle Pharmaceutical
10.12.1 Zhejiang Kangle Pharmaceutical Company Details
10.12.2 Zhejiang Kangle Pharmaceutical Business Overview
10.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Introduction
10.12.4 Zhejiang Kangle Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020)
10.12.5 Zhejiang Kangle Pharmaceutical Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antipyretic Analgesics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Paracetamol
Table 4. Key Players of Aspirin
Table 5. Key Players of Ibuprofen
Table 6. Key Players of Naproxen
Table 7. Key Players of Diclofenac
Table 8. Key Players of Oxaprozin
Table 9. Key Players of Dexibuprofen
Table 10. Key Players of Others
Table 11. Global Antipyretic Analgesics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Antipyretic Analgesics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Antipyretic Analgesics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Antipyretic Analgesics Market Share by Regions (2015-2020)
Table 15. Global Antipyretic Analgesics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Antipyretic Analgesics Market Share by Regions (2021-2026)
Table 17. Antipyretic Analgesics Market Market Trends
Table 18. Antipyretic Analgesics Market Drivers
Table 19. Antipyretic Analgesics Market Challenges
Table 20. Antipyretic Analgesics Market Restraints
Table 21. Global Antipyretic Analgesics Revenue by Players (2015-2020) (US$ Million)
Table 22. Global Antipyretic Analgesics Market Share by Players (2015-2020)
Table 23. Global Top Antipyretic Analgesics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Analgesics as of 2019)
Table 24. Global Antipyretic Analgesics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Antipyretic Analgesics Product Solution and Service
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 29. Global Antipyretic Analgesics Market Size Share by Type (2015-2020)
Table 30. Global Antipyretic Analgesics Revenue Market Share by Type (2021-2026)
Table 31. Global Antipyretic Analgesics Market Size Share by Application (2015-2020)
Table 32. Global Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 33. Global Antipyretic Analgesics Market Size Share by Application (2021-2026)
Table 34. North America Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 35. North America Antipyretic Analgesics Market Share by Type (2015-2020)
Table 36. North America Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 37. North America Antipyretic Analgesics Market Share by Application (2015-2020)
Table 38. North America Antipyretic Analgesics Market Size by Country (US$ Million) (2015-2020)
Table 39. North America Antipyretic Analgesics Market Share by Country (2015-2020)
Table 40. Europe Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 41. Europe Antipyretic Analgesics Market Share by Type (2015-2020)
Table 42. Europe Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 43. Europe Antipyretic Analgesics Market Share by Application (2015-2020)
Table 44. Europe Antipyretic Analgesics Market Size by Country (US$ Million) (2015-2020)
Table 45. Europe Antipyretic Analgesics Market Share by Country (2015-2020)
Table 46. Asia-Pacific Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 47. Asia-Pacific Antipyretic Analgesics Market Share by Type (2015-2020)
Table 48. Asia-Pacific Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 49. Asia-Pacific Antipyretic Analgesics Market Share by Application (2015-2020)
Table 50. Asia-Pacific Antipyretic Analgesics Market Size by Region (US$ Million) (2015-2020)
Table 51. Asia-Pacific Antipyretic Analgesics Market Share by Region (2015-2020)
Table 52. Latin America Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 53. Latin America Antipyretic Analgesics Market Share by Type (2015-2020)
Table 54. Latin America Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 55. Latin America Antipyretic Analgesics Market Share by Application (2015-2020)
Table 56. Latin America Antipyretic Analgesics Market Size by Country (US$ Million) (2015-2020)
Table 57. Latin America Antipyretic Analgesics Market Share by Country (2015-2020)
Table 58. Middle East & Africa Antipyretic Analgesics Market Size by Type (2015-2020) (US$ Million)
Table 59. Middle East & Africa Antipyretic Analgesics Market Share by Type (2015-2020)
Table 60. Middle East & Africa Antipyretic Analgesics Market Size by Application (2015-2020) (US$ Million)
Table 61. Middle East & Africa Antipyretic Analgesics Market Share by Application (2015-2020)
Table 62. Middle East & Africa Antipyretic Analgesics Market Size by Country (US$ Million) (2015-2020)
Table 63. Middle East & Africa Antipyretic Analgesics Market Share by Country (2015-2020)
Table 64. Mallinckrodt Pharmaceuticals Company Details
Table 65. Mallinckrodt Pharmaceuticals Business Overview
Table 66. Mallinckrodt Pharmaceuticals Product
Table 67. Mallinckrodt Pharmaceuticals Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 68. Mallinckrodt Pharmaceuticals Recent Development
Table 69. IOL Company Details
Table 70. IOL Business Overview
Table 71. IOL Product
Table 72. IOL Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 73. IOL Recent Development
Table 74. Anqiu Lu'an Pharmaceutical Company Details
Table 75. Anqiu Lu'an Pharmaceutical Business Overview
Table 76. Anqiu Lu'an Pharmaceutical Product
Table 77. Anqiu Lu'an Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 78. Anqiu Lu'an Pharmaceutical Recent Development
Table 79. Novacyl Company Details
Table 80. Novacyl Business Overview
Table 81. Novacyl Product
Table 82. Novacyl Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 83. Novacyl Recent Development
Table 84. BASF Company Details
Table 85. BASF Business Overview
Table 86. BASF Product
Table 87. BASF Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 88. BASF Recent Development
Table 89. Anhui BBCA Pharmaceuticals Company Details
Table 90. Anhui BBCA Pharmaceuticals Business Overview
Table 91. Anhui BBCA Pharmaceuticals Product
Table 92. Anhui BBCA Pharmaceuticals Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 93. Anhui BBCA Pharmaceuticals Recent Development
Table 94. Hubei Biocause Company Details
Table 95. Hubei Biocause Business Overview
Table 96. Hubei Biocause Product
Table 97. Hubei Biocause Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 98. Hubei Biocause Recent Development
Table 99. Xinhua Pharm Business Overview
Table 100. Xinhua Pharm Product
Table 101. Xinhua Pharm Company Details
Table 102. Xinhua Pharm Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 103. Xinhua Pharm Recent Development
Table 104. Granules India Limited Company Details
Table 105. Granules India Limited Business Overview
Table 106. Granules India Limited Product
Table 107. Granules India Limited Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 108. Granules India Limited Recent Development
Table 109. Huagang Pharm Company Details
Table 110. Huagang Pharm Business Overview
Table 111. Huagang Pharm Product
Table 112. Huagang Pharm Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 113. Huagang Pharm Recent Development
Table 114. Hebei Jiheng Pharmaceutical Company Details
Table 115. Hebei Jiheng Pharmaceutical Business Overview
Table 116. Hebei Jiheng Pharmaceutical Product
Table 117. Hebei Jiheng Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 118. Hebei Jiheng Pharmaceutical Recent Development
Table 119. Zhejiang Kangle Pharmaceutical Company Details
Table 120. Zhejiang Kangle Pharmaceutical Business Overview
Table 121. Zhejiang Kangle Pharmaceutical Product
Table 122. Zhejiang Kangle Pharmaceutical Revenue in Antipyretic Analgesics Business (2015-2020) (US$ Million)
Table 123. Zhejiang Kangle Pharmaceutical Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antipyretic Analgesics Market Share by Type: 2020 VS 2026
Figure 2. Paracetamol Features
Figure 3. Aspirin Features
Figure 4. Ibuprofen Features
Figure 5. Naproxen Features
Figure 6. Diclofenac Features
Figure 7. Oxaprozin Features
Figure 8. Dexibuprofen Features
Figure 9. Others Features
Figure 10. Global Antipyretic Analgesics Market Share by Application: 2020 VS 2026
Figure 11. Adults Case Studies
Figure 12. Children Case Studies
Figure 13. Antipyretic Analgesics Report Years Considered
Figure 14. Global Antipyretic Analgesics Market Size (US$ Million), YoY Growth 2015-2026
Figure 15. Global Antipyretic Analgesics Market Share by Regions: 2020 VS 2026
Figure 16. Global Antipyretic Analgesics Market Share by Regions (2021-2026)
Figure 17. Global Antipyretic Analgesics Market Share by Players in 2019
Figure 18. Global Top Antipyretic Analgesics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Analgesics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Antipyretic Analgesics Revenue in 2019
Figure 20. North America Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. United States Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Europe Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Germany Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. France Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. U.K. Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Italy Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Russia Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Nordic Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Rest of Europe Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Asia-Pacific Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. China Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Japan Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. South Korea Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Southeast Asia Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. India Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Australia Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Asia-Pacific Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Latin America Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Middle East & Africa Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Rest of Middle East & Africa Antipyretic Analgesics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 48. IOL Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 49. Anqiu Lu'an Pharmaceutical Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 50. Novacyl Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 51. BASF Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 52. Anhui BBCA Pharmaceuticals Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 53. Hubei Biocause Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 54. Xinhua Pharm Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 55. Granules India Limited Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 56. Huagang Pharm Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 57. Hebei Jiheng Pharmaceutical Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 58. Zhejiang Kangle Pharmaceutical Revenue Growth Rate in Antipyretic Analgesics Business (2015-2020)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed